Clinical Trials Database

Specialty/ Disorder

Study  Information

Purpose

PI Name
/Sponsor

More Information

Contact

Schizophrenia

This study is currently recruiting participants.

Population:
Adults age 18 to 40 

Setting:
Outpatient

This study is seeking volunteers for a clinical trial that may improve cognitive functioning. 

Participants take add-on valacyclovir or placebo for sixteen weeks and are compensated for their time. 

Eligibility:

  • 18 - 40 years old

  • Diagnosed with Schizophrenia or Schizoaffective Disorder within the past eight years

Faith Dickerson, PhD, MPH 

Sheppard Pratt Health System Towson, MD

(Coordinating site: Indiana University)

Click here to visit clinicaltrials.gov for more information

Cassie Stallings, R.N. or call 410-938-4356 

Schizophrenia

This study is currently recruiting participants.

Population:
Adults age 18 to 68

Setting:
Outpatient 

This study is seeking volunteers who experience unusual thinking or delusions for a clinical trial to improve symptoms. Participants take add-on d-cycloserine or placebo while receiving twelve weeks of cognitive behavior therapy and are compensated for their time.

Eligibility:

  • 18 - 68 years old

  • Diagnosed with Schizophrenia or Schizoaffective Disorder 

Faith Dickerson, PhD, MPH

Sheppard Pratt Health System Towson, MD

(Coordinating site: New York University School of Medicine)

Click here to visit clinicaltrials.gov for more information

Cassie Stallings, R.N. or call 410-938-4356

Dementia

This study is currently recruiting participants.

Population:
Adults age 50 to 85

Setting:
Outpatient

This is a 26-week, double-blind, multicenter, randomized, parallel group, placebo-controlled study to compare the efficacy and safety of treatment with SUVN-502 to placebo treatment in subjects with moderate Alzheimer's disease receiving stable doses of donepezil HCl and memantine HCl.


Scott Aaronson, MD

Sheppard Pratt Health System

Click here to visit clinicaltrials.gov for more information

Jennifer Sklar or call 410-938-3136

Depression

This study is currently recruiting participants.

Population:
Adolescents/young adults age 12-21

Setting:
Outpatient

This study's purpose is to evaluate the safety and efficacy of daily, active Neurostar® TMS (when compared with sham treatment) in adolescents meeting criteria for Major Depressive Disorder (MDD).

Scott Aaronson, MD

Sheppard Pratt Health System

Click here to visit clinicaltrials.gov for more information

Jennifer Sklar or call 410-938-3136

Mild Alzheimer's Dementia

This study is currently recruiting participants.

Population: Adults age 60 to 85

Setting: Outpatient

This study is seeking participants with mild Alzheimer's dementia. Eligible participants will take either the study drug piromelatine or placebo.

Scott Aaronson, MD

Sheppard Pratt Health System

Click here to visit clinicaltrials.gov for more information

Jennifer Sklar or call 410-938-3136

Major Depressive Disorder

This study is currently recruiting participants.

Population: Adults age 18 to 65

Setting: Outpatient

This study is seeking participants who have had only a partial response to antidepressant therapy. Participants will receive the study medication rapastinel or placebo in addition to their current antidepressant treatment.

Scott Aaronson, MD

Sheppard Pratt Health System

Click here to visit clinicaltrials.gov for more information

Jennifer Sklar or call 410-938-3136

Bipolar Disorder

This study is currently recruiting participants.

Population: Adults age 18+

Setting: Outpatient

This study is an Open-Label study of Transcranial Magnetic Stimulation (TMS) in patients with Bipolar Disorder who are currently depressed.

Scott Aaronson, MD

Sheppard Pratt Health System

Click here to visit clinicaltrials.gov for more information

Jennifer Sklar or call 410-938-3136

Alzheimer's Disease

This study is currently recruiting participants.

Populations: Adults age ≥ 50

Setting: Outpatient

This registry will be used to identify patients who have etiology diagnosed or suspected to be Alzheimer's disease and positive amyloid scans, and have indicated their interest in being contacted for an Eli Lilly and Company (Lilly) Alzheimer's Disease drug research trial.

Scott Aaronson, MD

Sheppard Pratt Health System

Click here to visit clinicaltrials.gov for more information

Jennifer Sklar or call 410-983-3136

If you are interested in participating in one of the above studies, please email or call the contact listed next to the studies we are actively recruiting for or complete the adjacent form to submit your contact information.

Interested in a Clinical Trial?

Select the study in which you are interested below: